Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 6.21671 | 84 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.66 | 87 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 6.37897 | 85 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 7.58693 | 91 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.77103 | 87 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 6.48744 | 87 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 6.80355 | 89 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 7.00529 | 89 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 6.92842 | 89 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 6.32861 | 84 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.42899 | 86 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.99222 | 88 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 6.34593 | 85 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 6.56673 | 86 |